Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

× No keyword cloud information.

84 in total

1. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.

Authors: G García-Calvo; A Parra; L Aguilar; C Ponte; M J Giménez; A Carcas; M Kinzig-Schippers; F Soriano
Journal: Antimicrob Agents Chemother Date: 2001-06 Impact factor: 5.191

Review 2. Pharmacoeconomics of intravenous drug administration.

Authors: S E Parker; P G Davey
Journal: Pharmacoeconomics Date: 1992-02 Impact factor: 4.981

3. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.

Authors: R Garraffo; H B Drugeon; P Dellamonica; E Bernard; P Lapalus
Journal: Antimicrob Agents Chemother Date: 1990-04 Impact factor: 5.191

4. Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.

Authors: R L Baker; R J Fass
Journal: Antimicrob Agents Chemother Date: 1984-08 Impact factor: 5.191

5. Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.

Authors: H C Standiford; G L Drusano; B Fitzpatrick; B Tatem; S C Schimpff
Journal: Antimicrob Agents Chemother Date: 1984-09 Impact factor: 5.191

Review 6. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors: E Saltiel; R N Brogden
Journal: Drugs Date: 1986-09 Impact factor: 9.546

7. [Antibacterial activity of antibiotics in human bile (author's transl)].

Authors: E B Helm; I Paulus; P M Shah; W Stille
Journal: Infection Date: 1976 Impact factor: 3.553

8. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.

Authors: H Lagast; J Klastersky; H Standiford; A Viollier
Journal: Infection Date: 1984 May-Jun Impact factor: 3.553

9. Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

Authors: J H Joshi; K A Newman; B W Brown; R S Finley; R L Ruxer; M A Moody; S C Schimpff
Journal: Support Care Cancer Date: 1993-07 Impact factor: 3.603

10. Disk diffusion and serial dilution tests of susceptibility of some pathogenic gram-negative bacilli and enterococci to carbenicillin and ampicillin.

Authors: C Garner; B Rosner; M Finland
Journal: Antimicrob Agents Chemother Date: 1975-08 Impact factor: 5.191